DEA schedule
Is dextroamphetamine, amphetamine and amphetamine dl-aspartate a controlled substance?
Federal schedule for dextroamphetamine, amphetamine and amphetamine dl-aspartate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Dextroamphetamine, amphetamine and amphetamine dl-aspartate is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted dextroamphetamine, amphetamine and amphetamine dl-aspartate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 11 prescription listings from 2 labelers, all Schedule II |
| DEA controlled substances list | Amphetamine: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Isomer or salt of the listed substance (21 CFR 1308) |
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Listed by name |
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Ester or salt of the listed substance |
Dextroamphetamine, Amphetamine and Amphetamine Dl-aspartate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 43975-277 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | ANI Pharmaceuticals, Inc. | CII |
| 43975-278 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | ANI Pharmaceuticals, Inc. | CII |
| 43975-279 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 | ANI Pharmaceuticals, Inc. | CII |
| 43975-280 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 | ANI Pharmaceuticals, Inc. | CII |
| 43975-281 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1 | ANI Pharmaceuticals, Inc. | CII |
| 43975-282 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 | ANI Pharmaceuticals, Inc. | CII |
| 68462-647 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate | tablet | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | GLENMARK PHARMACEUTICALS INC., USA | CII |
| 68462-649 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate | tablet | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | GLENMARK PHARMACEUTICALS INC., USA | CII |
| 68462-651 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate | tablet | 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 | GLENMARK PHARMACEUTICALS INC., USA | CII |
| 68462-652 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate | tablet | 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 | GLENMARK PHARMACEUTICALS INC., USA | CII |
| 68462-653 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate | tablet | 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 | GLENMARK PHARMACEUTICALS INC., USA | CII |
Questions
Is dextroamphetamine, amphetamine and amphetamine dl-aspartate a controlled substance?
Yes. Dextroamphetamine, amphetamine and amphetamine dl-aspartate is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Is dextroamphetamine, amphetamine and amphetamine dl-aspartate a narcotic?
No. The DEA list does not mark dextroamphetamine, amphetamine and amphetamine dl-aspartate as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is dextroamphetamine, amphetamine and amphetamine dl-aspartate?
Dextroamphetamine, amphetamine and amphetamine dl-aspartate is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Dextroamphetamine, Amphetamine and Amphetamine Dl-aspartate
- What is Dextroamphetamine, Amphetamine and Amphetamine Dl-aspartate used for?FDA label uses
- Central Nervous System Stimulants listFDA drug class
- NDC 43975-277Dextroamphetamine, Amphetamine and Amphetamine Dl-aspartate NDC record
- NDC 43975-278Dextroamphetamine, Amphetamine and Amphetamine Dl-aspartate NDC record
- NDC 43975-279Dextroamphetamine, Amphetamine and Amphetamine Dl-aspartate NDC record
- Schedule II drugs listDEA schedule